Cellular Responses to p53 Activation by Nutlin-3a
Cellular Responses to p53 Activation by Nutlin-3a
批准号:
8271293
负责人:
Carl G Maki
金额:
$30.19万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-13 至 2014-05-31
关键词:
ActinsAdverse effectsAneuploid CellsAneuploidyApoptosisAutomobile DrivingBiological AssayBreast Cancer CellCancer cell lineCell LineCellsChromosomesCisplatinCollectionCytoskeletal ModelingDNADNA DamageDNA biosynthesisDataDevelopmentDoseEpithelial CellsExcisionFamilyFocal AdhesionsG1 ArrestGenerationsGenomic InstabilityGlucocorticoid ReceptorGoalsGrantGrowthGuanosine Triphosphate PhosphohydrolasesHCT116 CellsHumanInvadedM cellMDM2 geneMYC geneMalignant NeoplasmsMammary glandMediatingMitosisNormal CellPathway interactionsPharmaceutical PreparationsPolyploid CellsProtein p53RU-486RadiationReceptor ActivationReportingResistanceSignal TransductionStressStress FibersTestingTherapeuticTherapeutic AgentsTissuesTumor Suppressor Proteinsabstractinganticancer researchbasecancer cellcancer therapycarcinogenesiscell growthcell motilitycell typeimmortalized cellin vivointerestkillingsmatrigelmigrationnutlin 3preventresponserhosmall moleculewound
中文摘要
项目概要/摘要:
野生型p53是一种有效的肿瘤抑制因子,可被DNA损伤和其他应激激活。一直
作为一种治疗策略,恢复野生型p53的功能一直受到相当大的关注。这一目标导致
Nutlin-3(Nutlin)是一种通过阻断野生型p53的表达来激活野生型p53的小分子,
MDM 2是细胞中p53活性的主要负调节因子。值得注意的是,Nutlin激活p53
通过非遗传毒性机制,因此其作为治疗剂的用途可以使组织免于有害的
与常见的DNA损伤药物相关的副作用。有效使用Nutlin要求其对
细胞被完全理解。我们已经研究了各种p53野生型细胞系对短暂的
Nutlin治疗。我们发现Nutlin激活p53可以促进细胞生长停滞或凋亡
依赖于生存途径的激活,我们已经确定了一个候选的生存因子,
Nutlin诱导的细胞凋亡。我们还发现Nutlin对细胞骨架组织有惊人的影响
和控制DNA核内复制。该补助金的目的是确定Nutlin介导的
p53激活对这些不同的细胞反应的影响。
英文摘要
Project Summary / Abstract:
Wild-type p53 is a potent tumor suppressor that is activated by DNA damage and other stresses. There has
been considerable interest in restoring wild-type p53 function as a therapeutic strategy. This goal has led to
the development of the Nutlin-3 (Nutlin), a small molecule that activates wild-type p53 by blocking its
interaction with MDM2, the primary negative regulator of p53 activity in cells. Notably, Nutlin activates p53
through a non-genotoxic mechanism, and thus its use as a therapeutic agent may spare tissues of deleterious
side-effects associated with common DNA damaging drugs. Effective use of Nutlin requires that its effects on
cells be fully understood. We have examined the response of various p53 wild-type cell lines to transient
Nutlin treatment. We find that p53 activation by Nutlin can promote growth arrest or apoptosis in cells
dependent on activation of survival pathways, and we have identified a candidate survival factor that protects
cells from Nutlin-induced apoptosis. We also find that Nutlin has surprising effects on cytoskeletal organization
and control of DNA endoreduplication. The purpose of this grant is to determine the effects of Nutlin-mediated
p53 activation on these various cellular responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A synthetic lethal approach for targeting p53 deficient triple negative breast cancer
-
批准号:10650026
-
项目类别:
-
资助金额:$22.16万
-
财政年份:2023
-
负责人:Carl G Maki
-
依托单位:
Targeting Prolyl Peptidases in Tamoxifen Resistant Breast Cancer
-
批准号:9461165
-
项目类别:
-
资助金额:$5.69万
-
财政年份:2017
-
负责人:Carl G Maki
-
依托单位:
Targeting Prolyl Peptidases in Tamoxifen Resistant Breast Cancer
-
批准号:9115348
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2016
-
负责人:Carl G Maki
-
依托单位:
Targeting Prolyl Peptidases in Tamoxifen Resistant Breast Cancer
-
批准号:9253372
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2016
-
负责人:Carl G Maki
-
依托单位:
Targeting Prolyl Peptidases in Tamoxifen Resistant Breast Cancer
-
批准号:9912119
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2016
-
负责人:Carl G Maki
-
依托单位:
Identification and Targeting Therapy Resistant Osteosarcoma
-
批准号:8814732
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2015
-
负责人:Carl G Maki
-
依托单位:
Modeling The Etiology of P53 Mutated Cancer Cells
-
批准号:8571884
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2013
-
负责人:Carl G Maki
-
依托单位:
Modeling The Etiology of P53 Mutated Cancer Cells
-
批准号:8704904
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2013
-
负责人:Carl G Maki
-
依托单位:
Cellular Responses to p53 Activation by Nutlin-3a
-
批准号:7735485
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2009
-
负责人:Carl G Maki
-
依托单位:
Cellular Responses to p53 Activation by Nutlin-3a
-
批准号:8471662
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2009
-
负责人:Carl G Maki
-
依托单位:
Cellular Responses to p53 Activation by Nutlin-3a
-
批准号:8073582
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2009
-
负责人:Carl G Maki
-
依托单位:
Physical and Functional Interactions Between PML & MDM2
-
批准号:6811808
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2004
-
负责人:Carl G Maki
-
依托单位:
Physical and Functional Interactions Between PML & MDM2
-
批准号:7425780
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2004
-
负责人:Carl G Maki
-
依托单位:
Physical and Functional Interactions Between PML & MDM2
-
批准号:6930623
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2004
-
负责人:Carl G Maki
-
依托单位:
Physical and Functional Interactions Between PML & MDM2
-
批准号:7263223
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2004
-
负责人:Carl G Maki
-
依托单位:
Physical and Functional Interactions Between PML & MDM2
-
批准号:7105102
-
项目类别:
-
资助金额:$23.45万
-
财政年份:2004
-
负责人:Carl G Maki
-
依托单位:
UBIQUITINATION AND STABILITY OF P53 AND P73
-
批准号:6174039
-
项目类别:
-
资助金额:$23.59万
-
财政年份:1999
-
负责人:Carl G Maki
-
依托单位:
p53 localization in normal and human tumor cells
-
批准号:7117863
-
项目类别:
-
资助金额:$24.76万
-
财政年份:1999
-
负责人:Carl G Maki
-
依托单位:
p53 localization in normal and human tumor cells
-
批准号:6823880
-
项目类别:
-
资助金额:$24.85万
-
财政年份:1999
-
负责人:Carl G Maki
-
依托单位:
p53 localization in normal and human tumor cells
-
批准号:6946513
-
项目类别:
-
资助金额:$25.35万
-
财政年份:1999
-
负责人:Carl G Maki
-
依托单位:
海外基金